Abstract
Some 86 heart transplant recipients under immunosuppressive therapy were vaccinated against hepatitis B using the vaccine Gen H-B-Vax-D, but 95.3% failed to develop protective levels of HBs-specific antibody (more than 10 U/l) after the third vaccination.
MeSH terms
-
Female
-
Heart Transplantation*
-
Hepatitis B / epidemiology
-
Hepatitis B / etiology*
-
Hepatitis B / prevention & control
-
Hepatitis B Vaccines*
-
Humans
-
Immunocompromised Host*
-
Immunosuppression Therapy / adverse effects
-
Male
-
Middle Aged
-
Postoperative Complications / epidemiology
-
Postoperative Complications / etiology*
-
Postoperative Complications / prevention & control
-
Transfusion Reaction*
-
Vaccination*